Dr. Solanki is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2160 S 1st Ave
# Maguire
Maywood, IL 60153Phone+1 708-216-2729
Education & Training
University of Chicago/University of Illinois College of Medicine at ChicagoResidency, Radiation Oncology, 2010 - 2014
Maimonides Medical CenterInternship, Transitional Year, 2009 - 2010
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 2009
Certifications & Licensure
IL State Medical License 2014 - 2026- American Board of Radiology Radiation Oncology
Clinical Trials
- Focal Salvage HDR Brachytherapy for Locally Recurrent Prostate Cancer in Patients Treated With Prior Radiotherapy Start of enrollment: 2017 Aug 28
- BEACON: HDR Brachytherapy, EBRT and STAD for the Treatment of Local and Pelvic Recurrence of Prostate Cancer After Radiation Therapy Start of enrollment: 2018 May 29
- A Study of Chemotherapy and Radiation Therapy Compared to Chemotherapy and Radiation Therapy Plus MEDI4736 (Durvalumab) Immunotherapy for Bladder Cancer Which Has Spread to the Lymph Nodes (The INSPIRE Study) Start of enrollment: 2021 Mar 17
- Join now to see all
Publications & Presentations
PubMed
- ACR Appropriateness Criteria® Pretreatment Staging of Urothelial Cancer: 2024 Update., Samantha J Barker, Esra Soylu, Brian C Allen, Moises Auron
Journal of the American College of Radiology. 2024-11-01 - A Systematic Review of Clinical Trials Comparing Radiation Therapy Versus Radical Prostatectomy in Prostate Cancer.Lauren Hekman, Athena Barrett, Dylan Ross, Eli Palaganas, Prashanth Giridhar
Clinical Genitourinary Cancer. 2024-10-01 - Prognostic Significance of Immune Cell Infiltration in Muscle-invasive Bladder Cancer Treated with Definitive Chemoradiation: A Secondary Analysis of RTOG 0524 and RTO...Zaker Rana, Sophia C Kamran, Amol C Shetty, Philip Sutera, Yang Song
European Urology Oncology. 2024-10-01
Authored Content
- Perspectives from Council of Affiliated Regional Radiation Oncology SocietiesJune 2019
- Perspectives from Council of Affiliated Regional Radiation Oncology SocietiesJune 2019
Press Mentions
‘STARPORT’ Trial Probes New Approach for Aggressive Prostate CancerAugust 16th, 2021- Medline Buyout Could Set off Wave of Private Equity Investment:June 9th, 2021
- Hines VA Hospital and Loyola University Chicago Physician Awarded $8.6M VA Research GrantJune 8th, 2021
- Join now to see all
Grant Support
- Veterans Affairs seamless phase II/III randomized trial of STAndard systemic theRapy with or without PET-directed local therapy for OligoRecurrenT prostate cancer (VA STARPORT)Veterans Affairs Office of Research and Development2021–2026
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
